-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
- Home
- About
- Media centre
- Bell en Gong Archief
- Wereldkankerdag
Wereldkankerdag
04/02/2019
KWF luidt de gong voor Wereldkankerdag
Johan van de Gronden is directeur van KWF Kankerbestrijding en luidt de gong voor Wereldkankerdag. Het KWF werkt samen met meer dan 160 organisaties om stil te staan bij de impact die kanker heeft.
KWF Kankerbestrijding is het grootste goede doel van Nederland en financiert ongeveer de helft van al het kankeronderzoek in Nederland.
Voor meer informatie: kwf.nl